相似文献
1
Repression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugs.
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18567-71. doi: 10.1073/pnas.0509316102. Epub 2005 Dec 13.
2
Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.
Mol Carcinog. 2009 Oct;48(10):942-52. doi: 10.1002/mc.20546.
3
The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Oncogene. 2001 Feb 1;20(5):645-53. doi: 10.1038/sj.onc.1204123.
4
R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
J Hepatol. 2007 May;46(5):849-57. doi: 10.1016/j.jhep.2006.11.017. Epub 2006 Dec 21.
5
Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
Cells. 2019 Jul 15;8(7):726. doi: 10.3390/cells8070726.
6
Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
J Neurochem. 2005 Feb;92(4):895-903. doi: 10.1111/j.1471-4159.2004.02932.x.
7
Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Endocr Rev. 2005 Dec;26(7):898-915. doi: 10.1210/er.2003-0034. Epub 2005 Aug 26.
8
9
Action of β-endorphin and nonsteroidal anti-inflammatory drugs, and the possible effects of nonsteroidal anti-inflammatory drugs on β-endorphin.
J Clin Anesth. 2017 Feb;37:123-128. doi: 10.1016/j.jclinane.2016.12.016. Epub 2017 Jan 9.
10
Involvement of PPAR gamma and E-cadherin/beta-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells.
Int J Cancer. 2007 Jul 15;121(2):248-56. doi: 10.1002/ijc.22646.
引用本文的文献
1
Advances in Diclofenac Derivatives: Exploring Carborane-Substituted N-Methyl and Nitrile Analogs for Anticancer Therapy.
ChemMedChem. 2025 Jun 2;20(11):e202500084. doi: 10.1002/cmdc.202500084. Epub 2025 Apr 14.
2
Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential.
Sci Rep. 2024 Dec 16;14(1):30488. doi: 10.1038/s41598-024-81414-x.
3
Turkish coffee has an antitumor effect on breast cancer cells in vitro and in vivo.
Nutr Metab (Lond). 2024 Sep 13;21(1):73. doi: 10.1186/s12986-024-00846-4.
4
Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer.
Molecules. 2023 Jun 29;28(13):5081. doi: 10.3390/molecules28135081.
5
R-etodolac is a more potent Wnt signaling inhibitor than enantiomer, S-etodolac.
Biochem Biophys Rep. 2022 Feb 19;30:101231. doi: 10.1016/j.bbrep.2022.101231. eCollection 2022 Jul.
6
5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis.
Br J Cancer. 2021 Jun;124(12):1959-1969. doi: 10.1038/s41416-021-01354-5. Epub 2021 Mar 30.
7
Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium.
Acta Crystallogr E Crystallogr Commun. 2021 Jan 19;77(Pt 2):134-137. doi: 10.1107/S2056989021000414. eCollection 2021 Feb 1.
8
Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Med Sci Monit. 2018 May 7;24:2864-2872. doi: 10.12659/MSM.910109.
9
Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer.
PPAR Res. 2017;2017:5879090. doi: 10.1155/2017/5879090. Epub 2017 Feb 19.
10
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.
Front Endocrinol (Lausanne). 2017 Feb 22;8:31. doi: 10.3389/fendo.2017.00031. eCollection 2017.
本文引用的文献
1
The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis.
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2525-30. doi: 10.1073/pnas.0409721102. Epub 2005 Feb 7.
2
A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12682-7. doi: 10.1073/pnas.0404875101. Epub 2004 Aug 16.
3
Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma.
Cancer Cell. 2004 Jun;5(6):565-74. doi: 10.1016/j.ccr.2004.05.014.
4
Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
J Biol Chem. 2004 Aug 20;279(34):35583-94. doi: 10.1074/jbc.M403143200. Epub 2004 Jun 9.
5
Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells.
Br J Cancer. 2004 Jul 5;91(1):153-63. doi: 10.1038/sj.bjc.6601901.
6
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.
Lancet. 2004 May 29;363(9423):1751-6. doi: 10.1016/S0140-6736(04)16299-5.
7
PPAR gamma signaling exacerbates mammary gland tumor development.
Genes Dev. 2004 Mar 1;18(5):528-40. doi: 10.1101/gad.1167804.
8
Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
J Am Coll Cardiol. 2004 Feb 18;43(4):519-25. doi: 10.1016/j.jacc.2003.09.043.
9
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3118-23. doi: 10.1073/pnas.0308648100. Epub 2004 Feb 18.
10
Beta-catenin signaling in prostate cancer: an early perspective.
Endocr Relat Cancer. 2003 Dec;10(4):537-60. doi: 10.1677/erc.0.0100537.
Zotero 插件